Typicality: | 0.400 |
Saliency: | 0.351 |
with the latest expiry in 2027 | 4 | temporal |
previously | 2 | temporal |
for identification of biliverdin reductase | 2 | purpose |
patent → be issued in → canada | 30 |
patent → be issued by → the canadian patent office | 4 |
negative | neutral | positive |
0.050 | 0.758 | 0.192 |
Raw frequency | 34 |
Normalized frequency | 0.351 |
Modifier score | 0.500 |
Perplexity | 30.277 |